Showing results (131-140 of 179) with videos related to
Sort By:
Pageof 18
Annals of Surgical Oncology|March 19, 2024
Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysisKavin Sugumar, Henry Stitzel, Victoria Wu, et al.Expert Review of Gastroenterology & Hepatology|June 4, 2020
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective studyMohamed A Abdallah, Nicha Wongjarupong, Mohamed A Hassan, et al.Oncology Reviews|January 30, 2026
Surgical cytoreduction versus systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms (GEP-NENS): a national cancer database analysis (NCDB)Amr Mohamed, Fasih A Ahmed, Omkar Pawar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal AdenocarcinomaAsfar S Azmi, Husain Yar Khan, Irfana Muqbil, et al.Endocrine-Related Cancer|February 11, 2025
Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomaShruti Chandra, Thorvardur R Halfdanarson, Erin E Carlson, et al.Journal of Gastrointestinal Oncology|January 18, 2021
Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancerKrishan R Jethwa, Shilpa Sannapaneni, Trey C Mullikin, et al.Annals of Surgery|April 5, 2019
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic CancerMark J Truty, Michael L Kendrick, David M Nagorney, et al.Annals of Surgery|April 18, 2023
Why the Treatment Sequence Matters: Interplay Between Chemotherapy Cycles Received, Cumulative Dose Intensity, and Survival in Resected Early-stage Pancreas CancerVictoria S Wu, Mohamedraed Elshami, Henry J Stitzel, et al.Journal of Immunotherapy and Precision Oncology|January 16, 2025
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 StudyAung Naing, Amit Mahipal, Milind Javle, et al.The Oncologist|December 13, 2019
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract CarcinomaSakti Chakrabarti, Tyler J Zemla, Daniel H Ahn, et al.Pageof 18